Insights Into Multiple Myeloma
Perspectives on current treatment practices regarding frontline therapy of multiple myeloma (MM), the evolving role of MRD testing in MM, current treatment practices in later lines of therapy, and attitudes toward recently introduced agents
Meeting Moderator
Sushil Bhardwaj, MD
Good Samaritan Hospital Suffern, NY, USA
Look Inside This Report
Download a sample of this report and start discovering the insights
Report Snapshot
Insights on the following therapies were obtained
- bortezomib
- carfilzomib
- ixazomib
- elotuzumab
- daratumumab
- lenalidomide
- pomalidomide
- selinexor
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- A moderated roundtable discussion focusing on treatment of MM was held on August 23, 2019, in Washington, DC, US
- Disease state and data presentations were developed in conjunction with a medical expert from Winship Cancer Institute
- The group of advisors comprised 8 community oncologists from the Northeast, US
- Data collection was accomplished through use of audience response system questioning and moderated discussion
